HYPR
Hyperfine, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.81
−3.13%Aug 26, 2026, 12:15 UTC
Hyperfine announced the publication of peer-reviewed NEURO PMR results and reported over 3,000 office brain MRI scans, supporting the growing use of the Swoop system in neurology practices during the first year of its neurology office launch.
Source:Aug 20, 2026, 12:15 UTC
Hyperfine announced FDA clearance of its next Optive AI software, enhancing image quality, clinical utility, ease of use, and isotropic imaging capability of the Swoop system across care settings.
Source:Aug 6, 2026, 20:05 UTC
Hyperfine, Inc. reported its second quarter 2026 financial results on August 6, 2026, highlighting growth in placements and revenue, gross margin expansion, and disciplined operating expenses.
Jul 1, 2026, 12:15 UTC
Hyperfine launched its next-generation Swoop® portable MRI system in Europe.
Source: